-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Tops Q1 EPS by 1c, provides guidance
-
-
-
-
-
-
-
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Tops Q2 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q4 EPS by 1c, provides guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4
-
1,222,626 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

